Quelle:
Chernyshov PV, Tomas-Aragones L, Manolache L, Svensson A, Marron SE, Evers AWM et al. Which acne treatment has the best influence on health-related quality of life? Literature review by the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes. J Eur Acad Dermatol Venereol. 2018 Sep;32(9):1410-1419.
Literatur:
[1] Chernyshov PV, Tomas-Aragones L, Manolache L, Svensson A, Marron SE, Evers AWM et al. Which acne treatment has the best influence on health-related quality of life? Literature review by the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes. J Eur Acad Dermatol Venereol. 2018 Sep;32(9):1410-1419.
[2] Rademaker M, Wishart JM, Birchall NM. Isotretinoin 5 mg daily for low grade adult acne vulgaris–a placebo-controlled, randomized double-blind study. J Eur Acad Dermatol Venereol 2014; 28: 747–754.
[3] McGrath EJ, Lovell CR, Gillison F, Darvay A, Hickey JR, Skevington SM. A prospective trial of the effects of isotretinoin on quality of life anddepressive symptoms. Br J Dermatol 2010; 163: 1323–1329.
[4] Oprica C, Emtestam L, Hagstr€omer L, Nord CE. Clinical and microbiological comparisons of isotretinoin vs. tetracycline in acne vulgaris. Acta Derm Venereol 2007; 87: 246–254.
[5] Fehnel SE, McLeod LD, Brandman J et al. Responsiveness of the acne-specific quality of life questionnaire (Acne-QoL) to treatment for acne vulgaris in placebo-controlled clinical trials. Qual Life Res 2002; 11: 809–816.
[6] Ozolins M, Eady EA, Avery A et al. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne. Health Technol Assess 2005; 9:iii–212.
[7] Thielitz A, Lux A, Wiede A, Kropf S, Papakonstantinou E, Gollnick H. A randomized investigator-blind parallel-group study to assess efficacy and safety of azelaic acid 15% gel vs. adapalene 0.1% gel in the treatment and maintenance treatment of female adult acne. J Eur Acad Dermatol Venereol 2015; 29: 789–796.
[8] Polakova K, Fauger A, Sayag M, Jourdan E. A dermocosmetic containing bakuchiol, Ginkgo biloba extract and mannitol improves the efficacy of adapalene in patients with acne vulgaris: result from a controlled randomized trial. Clin Cosmet Investig Dermatol 2015; 8: 187–191.
[9] Webster G, Thiboutot DM, Chen DM, Merikle E. Impact of a fixed combination of clindamycin phosphate 1.2%-benzoyl peroxide 2.5% aqueous gel on health-related quality of life in moderate to severe acne vulgaris. Cutis 2010; 86: 263–267.
[10] Stinco G, Piccirillo F, Valent F et al. Efficacy, tolerability, impact on quality of life and sebostatic activity of three topical preparations for the treatment of mild to moderate facial acne vulgaris. G Ital Dermatol Venereol 2016; 151: 230–238